Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapinarof cream 1% generic vs VTAMA in plaque psoriasis
NCT06742957Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tapinarof in plaque psoriasis, sponsored by Teva Pharmaceutical Industries Ltd.. Started Dec 2024; status: completed.
02
Drugs
tapinarof
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06742957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06742957.